Imugene Limited
Clinical trials sponsored by Imugene Limited, explained in plain language.
-
Experimental virus therapy for solid tumors shows early promise in terminated trial
Disease control TerminatedThis early-phase study tested a new treatment called onCARlytics (CF33-CD19), a virus designed to infect and kill cancer cells, given together with another drug (blinatumomab) in adults with advanced solid tumors that had not responded to prior therapies. The trial aimed to find …
Phase: PHASE1 • Sponsor: Imugene Limited • Aim: Disease control
Last updated May 01, 2026 15:58 UTC
-
Experimental lung cancer vaccine shows early promise in small trial
Disease control TerminatedThis early-phase study tested a new immunotherapy called IMU-201 in 24 adults with advanced non-small cell lung cancer. The treatment aims to help the body's immune system fight cancer by targeting a protein called PD-1. Some participants received IMU-201 alone, while others got …
Phase: PHASE1 • Sponsor: Imugene Limited • Aim: Disease control
Last updated Apr 29, 2026 15:15 UTC